Get the Stockscreener App
0.0715
39.20%
-0.0461
Azitra Inc stock is traded at $0.0715, with a volume of 2.67M.
It is down -39.20% in the last 24 hours and down -56.80% over the past month.
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
See More
Previous Close:
$0.1176
Open:
$0.1207
24h Volume:
2.67M
Relative Volume:
3.36
Market Cap:
$4.33M
Revenue:
$7,500
Net Income/Loss:
$-10.96M
P/E Ratio:
-0.0312
EPS:
-2.2943
Net Cash Flow:
$-11.41M
1W Performance:
+0.00%
1M Performance:
-56.80%
6M Performance:
-66.42%
1Y Performance:
-86.87%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.0518
$1.09
Azitra Inc Stock (AZTR) Company Profile
Name
Azitra Inc
Sector
Industry
Phone
203 646 6446
Address
21 Business Park Drive, Branford
Compare AZTR vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTR
Azitra Inc
|
0.0715 | 4.33M | 7,500 | -10.96M | -11.41M | -2.2943 |
VRTX
Vertex Pharmaceuticals Inc
|
523.93 | 132.80B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.02 | 82.88B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
200.10 | 79.89B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
873.71 | 54.94B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
377.63 | 42.72B | 5.76B | 514.49M | 1.10B | 4.4813 |
Azitra Inc Stock (AZTR) Latest News
Azitra, Inc. (AZTR) Sets 1-for-10 Reverse Split Effective Oct. 26 - TradingView
Azitra, Inc. Announces Reverse Stock Split - PR Newswire
Azitra advances skin rash treatment trial to second cohort By Investing.com - Investing.com Nigeria
Azitra advances skin rash treatment trial to second cohort By Investing.com - Investing.com South Africa
Azitra advances skin rash treatment trial to second cohort - Investing.com
Azitra advances ATR04-484 trial for cancer trea... - Pluang
Azitra, Inc. Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance - PR Newswire
Azitra, Inc. Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance - Yahoo Finance
AZTR Forecast — Price Target — Prediction for 2027 - tradingview.com
Azitra Launches At-the-Market Equity Offering Program - The Globe and Mail
Azitra Launches $3.5 Million At-The-Market Stock Offering - Minichart
Form 424B5 Azitra Inc For: 28 September By Investing.com - Investing.com Nigeria
Form 424B5 Azitra Inc For: 28 September By Investing.com - Investing.com South Africa
Azitra Launches $3.5 Million ATM Equity Program With A.G.P./Alliance Global Partners - tradingview.com
A 3% fee on gross proceeds applies if Azitra (AZTR) sells stock under its new agreement. - Stock Titan
AZTR: Updated Valuation Reflects Cosmetic and EGFRi Rash Programs - finance.yahoo.com
Enterprise value to EBITDA forward of Azitra Inc – AMEX:AZTR - tradingview.com
Azitra at H.C. Wainwright conference: pipeline leans on skin bacteria - Investing.com
Azitra at H.C. Wainwright conference: pipeline leans on skin bacteria - Investing.com India
Azitra at H.C. Wainwright conference: pipeline leans on skin bacteria By Investing.com - Investing.com Canada
Azitra Inc (AZTR) Ticks Higher: Micro-Cap Biotech Holds Above $0.17 SupportCovered Call Trade - siam.in
Azitra Inc (AZTR) Ticks Higher: Micro-Cap Biotech Holds Above $0.17 SupportOBV Divergence - careplusvn.com
Azitra to Present Corporate Update at Investment Conference - TipRanks
Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire
Azitra's COO to update on clinical progress and new cosmetic protein data at H.C. Wainwright conference. - Pluang
Initial data on a program targeting fine lines and wrinkles will be shared by Azitra - Stock Titan
Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Lelezard
Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
AZTR News | AZITRA INC (NYSEARCA:AZTR) - ChartMill
Azitra Inc (AZTR) Holds at $0.17 as Tight Range Between $0.16 Support and $0.18 Resistance PersistsFibonacci Extension - dars.gov.et
Azitra Inc (AZTR) Holds at $0.17 as Tight Range Between $0.16 Support and $0.18 Resistance PersistsSentiment Extreme - careplusvn.com
Azitra Inc (AZTR) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Azitra (AZTR) Trading: Closes 13.25% Higher at $0.15; Immediate View: the Near-Term Reference Band Stretches From $0.14 to $0.16 under the Current SnapshotFibonacci Entry Signals - vinanet.vn
Azitra (AZTR) Levels: Finishes 4.81% Higher at $0.13 in the Current Update; Range Check - vinanet.vn
Azitra (AZTR) Levels: Finishes 4.81% Higher at $0.13 in the Current Update; Range Check - siam.in
Azitra Regains NYSE American Listing Compliance Status - The Globe and Mail
Azitra (NYSE:AZTR) Strengthens Market Position After Listing Milestone - Kalkine Media
Branford bioscience firm regains NYSE compliance - Hartford Business Journal
Azitra Regains NYSE American Listing Compliance Status - TipRanks
Azitra regains compliance with NYSE American listing standards - Investing.com
Azitra regains compliance with NYSE American li... - Pluang
Azitra Regains NYSE American Compliance; .BC Indicator to Be Removed - TradingView
Azitra (NYSE: AZTR) wins back listing under new NYSE watch period - Stock Titan
Azitra regains compliance with NYSE American listing standards By Investing.com - Investing.com UK
Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards - PR Newswire
Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards - Yahoo Finance
Azitra (AZTR) Earnings Comparison: The Bottom-Line Figure Trails Its Comparison in the Available Record; Post-Report Move: Shares Fall 7.61% in the Latest ReadingROA Comparison - vinanet.vn
Azitra (AZTR): Nantahala Capital reports 6.48M-share, 9.99% beneficial stake - Stock Titan
Nantahala Capital Partners (AZTR) discloses 8.40% beneficial stake in Azitra - Stock Titan
Azitra, Inc. (AZTR) stock price, news, quote and history - Yahoo Finance Australia
Azitra Inc Stock (AZTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.09%
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):